Sea Crest Wealth Management, LLC Anavex Life Sciences Corp. Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$7.31 - $12.84 $31,981 - $56,175	4,375 New	4,375 $44,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $127,350 - $231,296	-13,075 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$16.88 - $23.31 $23,632 - $32,634	-1,400 Reduced 9.67%	13,075 $227,000
Q3 2021 Nov 16, 2021	BUY	$16.82 - $25.75 $10,933 - $16,737	650 Added 4.7%	14,475 $260,000
Q2 2021 Aug 12, 2021	BUY	$10.16 - $28.86 $140,462 - $398,989	13,825 New	13,825 $316,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $436M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.